Jump to main content

yr 〜
yr

Search results 4

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
Digital博士論文障害者向け資料あり
須賀, 孝慶群馬大学医学系研究科2019-03-22
National Diet Library
  • Subject HeadingAlpha cell Diabetes Sodium glucose cotransporter SGLT Phloretin Sotagliflozin

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study). 10

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study). 10
Digital博士論文障害者向け資料あり
Nakajima, Hiroki, Okada, Sadanori, Mohri, Takako, Kanda, Eiichiro, Inaba, Naoyuki, Hirasawa, Yoko, Seino, Hiroaki, Kuroda, Hisamoto, Hiyoshi, Toru, Niiya, Tetsuji, Ishii, HitoshiBioMed Central2018-03-01Diabetology and metabolic syndrome
National Diet Library
  • Subject Heading...glycemic agent Sodium glucose cotransporters 2 inhibitors SGLT2 inhibitor...
  • Note (General)...he benefits of sodium glucose cotransporters 2 (SGLT2) inhibitors in pati...

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
Digital博士論文
須賀, 孝慶群馬大学医学系研究科2019-03-22
Available onlineOther Libraries in Japan
  • Subject HeadingAlpha cell Diabetes Sodium glucose cotransporter SGLT Phloretin Sotagliflozin

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).
Digital博士論文
Nakajima, Hiroki, Okada, Sadanori, Mohri, Takako, Kanda, Eiichiro, Inaba, Naoyuki, Hirasawa, Yoko, Seino, Hiroaki, Kuroda, Hisamoto, Hiyoshi, Toru, Niiya, Tetsuji, Ishii, HitoshiBioMed Central2018-03-01Diabetology and metabolic syndrome10p.Article No.11-
Available onlineOther Libraries in Japan
  • Subject Heading...glycemic agent Sodium glucose cotransporters 2 inhibitors SGLT2 inhibitor...
  • Note (General)...he benefits of sodium glucose cotransporters 2 (SGLT2) inhibitors in pati...

Reached to the end of result.

RSS